12th Dec 2018 09:19
LONDON (Alliance News) - 4d Pharma PLC on Wednesday noted a recent fall in its share price, but said is not aware of any company-related reasons for the drop.
The pharmaceutical company confirmed that all clinical study timelines continue to progress as expected.
4d Pharma shares were trading 0.1% lower early Wednesday at 88.95 pence each. On Tuesday, the stock closed down 30%.
Related Shares:
DDDD.L